by Othersen, J.B. et al.
Department of Biostatistics, Bioinformatics and Epidemiology, Division of Nephrology, Medical University of South Carolina, USA
Department of Biostatistics, Bioinformatics and Epidemiology, Division of Nephrology, Medical University of South Carolina, USA
None of the 592 patients estimated to be in stage 3 or 4 of chronic kidney disease developed nephrogenic systemic fibrosis after exposure to gadolinium.
Nephrol. Dial. Transplant. 2007; 11:3179-85